Saturday, January 23, 2016

7:00-7:45 am Registration and Breakfast
7:45-8:30 Overview: Addressing Pain/Screening and Recognizing Addiction | Opioid Dependence and Its Treatment | The Drug Addiction Treatment Act of 2000
Elinore McCance-Katz, MD, PhD
8:30-9:15 Good Prescribing Practices | Using the New & Improved Rhode Island (RI) Prescription Monitoring Program | RI Controlled Substance Regulations for Prescribers
James V. McDonald, MD, MPH
Medication Assisted Treatment and Evidence-Based Counseling for Opioid Use Disorders | Resources in the Community for Opioid Use Disorder Treatment Services: OTPs
Elinore McCance-Katz, MD, PhD
9:45-10:00 Question and Answer Session
10:00-10:15 Break
10:15-11:15 General Opioid Pharmacology & Pharmacology of Buprenorphine/Safety and Efficacy of Buprenorphine
Peter D. Friedmann, MD, MPH
11:15-11:45 Medical Center | Opioid Treatment Program | Patient Assessment and Selection
Laura Levine, MD
11:45-12:15 pm Clinical Use of Buprenorphine: Induction, Stabilization, Maintenance, & Withdrawal
Elinore McCance-Katz, MD, PhD
12:15-12:30 Question and Answer Session
12:30-1:00 Small Group/Case Discussions
1:00-1:45 Lunch
1:45-2:25 Clinical Management
Alan L. Gordon, MD
2:25-2:45 Confidentiality, Medical Records, Office Policies & Procedures
Alan L. Gordon, MD
2:45-3:25 Pain Patients and Other Special Populations
Josiah D. Rich, MD
3:25-3:35 Question and Answer Session
3:35-4:05 Break
4:05-4:35 Small Group/Case Discussions
4:35-5:05 Opioid Overdose Prevention and Appropriate Clinical Use of Naloxone
Traci C. Green, PhD
5:05-5:20 pm Completion of DEA Waiver
Elinore McCance-Katz, MD, PhD